Globe Life (NYSE:GL) Stock Price Expected to Rise, TD Cowen Analyst Says

Globe Life (NYSE:GL) had its price target lifted by TD Cowen from $182.00 to $199.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s target price indicates a potential upside of 43.45% from the company’s current price.

Several other equities analysts have also issued reports on GL. Morgan Stanley cut their price objective on shares of Globe Life from $179.00 to $177.00 and set an “overweight” rating on the stock in a report on Monday, November 17th. Wells Fargo & Company decreased their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Cowen reissued a “buy” rating on shares of Globe Life in a research note on Thursday. Truist Financial boosted their target price on Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, October 24th. Finally, Piper Sandler reissued an “overweight” rating and set a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Nine investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $165.00.

Globe Life Stock Up 2.8%

Globe Life stock traded up $3.82 during mid-day trading on Thursday, reaching $138.73. The stock had a trading volume of 143,114 shares, compared to its average volume of 618,234. The company has a 50-day moving average price of $133.82 and a two-hundred day moving average price of $132.27. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life has a one year low of $103.71 and a one year high of $147.83. The company has a market capitalization of $11.04 billion, a price-to-earnings ratio of 10.05 and a beta of 0.48.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter last year, the firm posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. On average, analysts expect that Globe Life will post 13.87 EPS for the current fiscal year.

Institutional Investors Weigh In On Globe Life

A number of hedge funds have recently made changes to their positions in GL. Citigroup Inc. boosted its holdings in Globe Life by 54.7% in the first quarter. Citigroup Inc. now owns 76,389 shares of the company’s stock valued at $10,062,000 after purchasing an additional 27,021 shares in the last quarter. National Bank of Canada FI grew its holdings in shares of Globe Life by 4.2% in the 1st quarter. National Bank of Canada FI now owns 54,273 shares of the company’s stock worth $7,149,000 after acquiring an additional 2,182 shares during the period. Townsquare Capital LLC raised its position in Globe Life by 22.7% during the first quarter. Townsquare Capital LLC now owns 3,978 shares of the company’s stock worth $524,000 after acquiring an additional 735 shares during the last quarter. SouthState Corp purchased a new stake in Globe Life during the 1st quarter worth about $43,000. Finally, Public Sector Pension Investment Board raised its holdings in Globe Life by 3.3% in the 1st quarter. Public Sector Pension Investment Board now owns 22,472 shares of the company’s stock valued at $2,960,000 after acquiring an additional 715 shares during the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.